Alcon (ALC) EPS (Basic) (2009 - 2026)

Alcon (ALC) posted EPS (Basic) of $0.84 for Q1 2026, up 8.64% on a QoQ basis from $0.77 in Q4 2025.

Analysis

Alcon (ALC) EPS (Basic) (2009 - 2026) Analysis & Trends

Alcon has reported EPS (Basic) for 11 years, with the latest figure at $0.84 in Q1 2026.

On a quarterly basis, EPS (Basic) changed N/A year-over-year to $0.84 in Q1 2026; TTM through Jun 2026 was $2.41, a 2.92% increase from a year earlier, with the FY2025 full-year figure at $3.08, up 0.64% from the prior year.
EPS (Basic) was $0.84 for Q1 2026 at Alcon, up from $0.77 in the prior quarter.
The five-year high for EPS (Basic) was $0.84 in Q1 2026, with the low at -$0.18 in Q4 2023.
Average EPS (Basic) over 5 years is $0.51, with a median of $0.52 recorded in 2023.
The sharpest annual moves came in 2023 and 2024: EPS (Basic) slumped 359.16% in 2023, then surged 493.39% in 2024.
Over 5 years, EPS (Basic) stood at $0.07 in 2022, then plunged by 359.16% to -$0.18 in 2023, then soared by 493.39% to $0.73 in 2024, then increased by 6.67% to $0.77 in 2025, then gained by 8.64% to $0.84 in 2026.
The last three EPS (Basic) figures came in at $0.84 (Q1 2026), $0.77 (Q4 2025), and $0.8 (Q3 2025), per Business Quant data.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EPS (Basic) (Qtr)
1	Abbott Laboratories	183.04 Bn	177.44 Bn	7.27 Bn	0.53
2	Intuitive Surgical	125.02 Bn	119.81 Bn	1.96 Bn	2.32
3	Medtronic	117.84 Bn	109.02 Bn	6.34 Bn	1.16
4	Stryker	105.50 Bn	102.02 Bn	4.50 Bn	3.33
5	Boston Scientific	66.27 Bn	65.73 Bn	3.85 Bn	0.62
6	Edwards Lifesciences	49.60 Bn	45.35 Bn	1.35 Bn	0.42
7	Alcon	33.70 Bn	32.24 Bn	1.68 Bn	-
8	Dexcom	32.06 Bn	30.11 Bn	830.00 Mn	0.65
9	Steris	21.02 Bn	20.54 Bn	684.20 Mn	2.06
10	Zimmer Biomet Holdings	18.20 Bn	17.79 Bn	1.54 Bn	1.04

Historic Data

Download Data